Oncogenex

Oncogenex develops novel therapeutics targeting mechamisms of treatment resistance in cancer

placeSeattle, Washington, United States calendar_todayFounded 2000 groups12 employees language oncogenex.com

Registered entities

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital343%
Private equity114%
Other / undisclosed343%
Coming soon